SEC Form 4 · accession 0001144204-15-041066
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anton Gueth
Director
Period of report
Jul 2, 2015
Accepted (ET)
Jul 6, 2015 · 12:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 2, 2015 | A | 22,000 | $0.001 | A | 22,000 | D |
Table II — derivative securities
No Table II lines on this filing.